Daniel Karlin
Chief Medical Officer at Definium Therapeutics, Inc. (DFTX); Chief Medical Officer at Mind Medicine (MindMed) Inc. (DFTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.1M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 29SEC | DFTXDefinium Therapeutics, Inc. | Sell Plan | 10,853792,846 held (−1%) | $36.57 | $397K | -12.2% |
| Jun 26SEC | DFTXDefinium Therapeutics, Inc. | Sell Plan | 10,035503,282 held (−2%) | $45.03 | $452K | -28.7% |
| Mar 26SEC | DFTXDefinium Therapeutics, Inc. | Sell Plan | 8,018413,317 held (−2%) | $18.47 | $148K | +73.8% |
| Dec 29SEC | DFTXMind Medicine (MindMed) Inc. | Sell Plan | 5,600425,025 held (−1%) | $13.15 | $74K | +144.1% |
- Sell
Chief Medical Officer Daniel Karlin sold $397K of DFTX at $36.57 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Daniel Karlin sold $452K of DFTX at $45.03 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Daniel Karlin sold $148K of DFTX at $18.47 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Daniel Karlin sold $74K of DFTX at $13.15 — pre-scheduled 10b5-1 plan sale.